Results 241 to 250 of about 1,126,665 (298)

KL-6 Mucin as Serum Tumor Marker of Metastatic Renal Cancer: A Case Report. [PDF]

Case Rep Urol
Ishida K, Hasegawa G, Takada T, Ogose A, Kawaguchi G, Ikeda Y, Nishiyama H, Hara N, Nishiyama T.   +8 more
europepmc   +1 more source

Prognostic Implications of Sleep Architecture for Patients Admitted to the Intensive Care Unit With Status Epilepticus

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Status epilepticus (SE) is associated with significant mortality. Sleep architecture may reflect normal brain function. Impaired sleep architecture is associated with poorer outcomes in numerous conditions. Here we investigate the association of sleep architecture in continuous EEG (cEEG) with survival in SE.
Ran R. Liu, Marcus C. Ng, Gavin P. Winston, Sabrina Schaly, Garima Shukla, Lysa Boissé Lomax   +5 more
wiley   +1 more source

Rational design of gold nanoparticle-based chemosensors for detection of the tumor marker 3-methoxytyramine. [PDF]

Chem Sci
Franco-Ulloa S, Cesari A, Zanoni G, Riccardi L, Wallace J, Mascitti BB, Rastrelli F, Mancin F, De Vivo M.   +8 more
europepmc   +1 more source

The Differences in Expression of Tumor Marker KI-67 and Proliferation Cell Nuclear Antigen (PCNA) in Ameloblastoma with Histopathological Subtypes Follicular, Plexiform, and Mixed (Follicular-Plexiform). [PDF]

Eur J Dent
Purwoyudho IGPS, Kamadjaja DB, Danudiningrat RMCP, Amir MS, Rizqiawan A, Mulyawan I, Prasetio O.   +6 more
europepmc   +1 more source

DNA-methylation age and accelerated epigenetic aging in blood as a tumor marker for predicting breast cancer susceptibility. [PDF]

Aging (Albany NY)
Jung SY, Yu H, Deng Y, Pellegrini M.
europepmc   +1 more source

Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early-Stage Malignant Melanoma. [PDF]

Cancer Med
Polivka J, Gouda MA, Sharif M, Pesta M, Huang H, Treskova I, Woznica V, Windrichova J, Houfkova K, Kucera R, Fikrle T, Ricar J, Pivovarcikova K, Topolcan O, Janku F.   +14 more
europepmc   +1 more source

Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial. [PDF]

BMC Med
Xu Q, Huang K, Tong L, Yan D, Zhao Y, Yang H, Jin W, Zhang L, Cai J, Chen Q.   +9 more
europepmc   +1 more source

Study of Glutathione S-Transferase, its Isoenzyme (Pi) and Tumor Marker (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment).

J Pharm Bioallied Sci
Hawale D, Abichandani L, Ambad R.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor markers

Current Problems in Surgery, 1982
Several substances, referred to as tumor markers, are associated with neoplasms development. The specificity of these cancer related substances or antigens depends on their nature (onco-fetal antigens, placental antigens) or on their concentration and physico-chemical forms (hormones, exocrine products, enzymes,...).
H P, Ewing, B D, Newsom, J D, Hardy
openaire   +4 more sources